chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Pt received Td vaccine at approx 2:30 PM, 8/12/04. States became short of breath approx 15-20 min after vaccine given. Also light headed, was shopping and continued this activity. Later called nurse at ER and was told to take Benadryl. Spoke with her Dr. today and was told to continue Benadryl. Sx improving.
2 apnea episodes @ home w/in 36hr p/vax;lifeless, limp mom did mouth to mouth resuc;afeb;
L arm swelling at site of smallpox vaccine inoculation.  New pustular acne-like lesions that spread from L shoulder to upper chest, back, and R shoulder.  Also felt fatigued with sore throat and swollen cervical lymph nodes x24hr.  Symptoms resolved with Advil prn and rash resolving within 24-48h.
Shoulder and arm pain, unable to move arm last night (3/7/19), but improving a little this morning (3/8/19).
Pt developed throbbing, pulsing pain down her entire Right lateral Ribcage, by day 5 Post Covid vaccination.  Vx admin to R side. + Mild pleurisy also.
09/13/2021 Immediately after vaccination patient was feeling faint, medical was contacted and he was put in a wheel chair and blood pressure was checked 86/48 and three bottles of Gatorade was given and waiting a hour for observation, you check blood within normal range. 09/15/201 Dr. had chest pain and EKG it was normal. She recommended that she go to the ER to check for blood clot and it was done he signed waiver. Chest wall pain and monitoring symptoms 09/15/22021  new med Naprosyn 500mg twice daily after meals. Patient states still having chest wall pain improving but still on going issue.
Symptoms I experienced included fever (not sure how high) with chills/sweating, intense body aches/pains, fatigue, and headache. Symptoms I think are not part of the vaccine side effects include cough (mild mucus), sinus pain, stuff/runny nose (painful burning sensation when I blow my nose), some scratchiness in ears and throat, and loss of taste and smell. The last one (no taste/smell), is the most unusual, I'v never had this before.
COVID Vaccine Breakthrough Case  Pfizer Dose 1 1/13/21 (lot NA) Pfizer Dose 2 2/3/21 (lot NA) COVID Positive 12/10/21  12/10/21: Acute hypoxemic respiratory failure secondary to COVID-19.  Patient will be treated with remdesivir and dexamethasone and azithromycin and supplemental oxygen and breathing treatments.  12/15/21: Patient is a long-term care nursing home patient with dementia who presented with acute hypoxemic respiratory failure secondary to COVID-19 pneumonia. Patient was treated with remdesivir and dexamethasone, oxygen and nebulizers, and antibiotics to prevent secondary infection.  Patient progressively did well.  He has been oxygenating well.  Patient will be discharged back to nursing home with continued Levaquin for 3 days and dexamethasone for a week
Chest palpation, sharp chest pain,  shortness of breath congestion, fever,cough,sore throat
This spontaneous report as received from a registered nurse refers to unspecified number of patients of unknown age and gender. On an unknown date, the patients were vaccinated with improperly stored RECOMBIVAX HB Lot#J014855 and J009051 (dose was not reported). No adverse events were reported. This is one of several reports received from the same source. Additional information has been requested.
Redness with moderate pain and mild swelling beginning at injection site and spread distally/down arm. Began small in size but currently approx. 3" x 6". Started 2 days after receiving second dose. I had no issue with the first dose.
Urticaria treated with Benadryl 12.5mg po q6h X 24 hours then prn. Onset 4/12/02.
Vomiting, diarrhea and stomach pains for 3 weeks couldn?t keep anything down or in me
This spontaneous report was received from a certified medical assistant, via company representative, concerning an 11 year old male patient. The patient's pertinent medical history, concurrent conditions, drug reactions or allergies were unspecified by reporter. On an unknown date, the patient was vaccinated with a dose of GARDASIL 9, 0.5 ml (dose number, route, anatomical location, lot number and expiration date were unspecified). The patient was concomitantly vaccinated with TDAP and MENACTRA. On an unknown date in March 2016 (reported as "within the last two weeks"), the patient was "out for about 30 seconds". Then, the patient was taken to the emergency room (ER) of an unspecified hospital where a computerized axial tomography (CAT) scan was performed. The reporter did not discuss the results of the CAT scan. It was not reported if the patient was admitted to the hospital or not. The outcome of the passed out was unknown. The relatedness between the event and GARDASIL 9 was not reported. Additional information has been requested.
day 3 after vaccine pt had diarrhea and day 4 pt had dizziness and weakness
When they injected it into arm I had a warming sensation going into shoulder and front of neck. It was almost like when they give an MRI and give the contrast. It was just my shoulder and into neck. I thought it was just me, and the pharmacist checked my shoulder and it was hot to the touch. We waited and the temperature got better and around 15 mins it was gone. I waited at pharmacy for 30 minutes since I do have allergies to antibiotics. I went ahead and left and as I was walking out the store I got light headed. When I was driving the left side of throat felt like it was getting larger and it was swelling. When I got home it wasn't going away and I was drinking water and hadn't really eaten anything and a couple hours after I ended up eating and couldn't really swallow the food. I called my Doctor and they thought it was weird because it was 2-3 hours after vaccine. Solid foods were hard to swallow but liquids was OK. It wasn't getting better so after around 4 hours my Doctor told me to take Benadryl and within 5 minutes it was gone and I could swallow again and the swelling went down. My Doctor thinks I had a slight reaction but not enough to have full anaphylactic reaction. I had Benadryl for 2 days. They told me to take Benadryl for 2nd dose.
A nurse reported that a 53 year old male received 23-valent pneumococcal vaccine and "is not responding". Additional information received on 5/23/01, indicated that the pt has a history of IgG deficiency and "did not make an immune response" following receipt of 23-valent pneumococcal vaccine on 4/01 with his 1st dose. See HQ0004423APR2001.
Client reports that her arm is still very sore and pain is radiating up her neck and down her arm.
This case was reported by a pharmacist via call center representative and described the occurrence of rash in a 17-year-old malel patient who received BOOSTRIX (batch number 45MH5, expiry date 11th February 2017). Concurrent medical conditions included hospitalization. Concomitant products included Normal Saline and ZOFRAN. On 19th April 2015, the patient received BOOSTRIX .5 ml. On 19th April 2015, lelss than a day after receiving BOOSTRIX, the patient experienced rash. On an unknown date, the outcome of the rash was recovered/resolved. The reporter considered the rash to be possibly related to BOOSTRIX. This was 1 of the 2 cases received from the same reporter. Additional details provided as follows: Pharmacist reported adverse events for a patient in the hospital. The patient developed a localized rash (pharmacist believes rash was in area of injection). No treatment was given for this rash.
chills, diaphoresis, fatigue, fever, congestion, rhinorrhea, sinus pressure, sinus pain, sore throat, nausea
arm pain, tenderness on the arm area, soreness; underneath the injection site there was a slight red area; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (arm pain, tenderness on the arm area, soreness) and VACCINATION SITE ERYTHEMA (underneath the injection site there was a slight red area) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025L50A) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Jan-2021, the patient experienced VACCINATION SITE PAIN (arm pain, tenderness on the arm area, soreness) and VACCINATION SITE ERYTHEMA (underneath the injection site there was a slight red area). At the time of the report, VACCINATION SITE PAIN (arm pain, tenderness on the arm area, soreness) and VACCINATION SITE ERYTHEMA (underneath the injection site there was a slight red area) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Left arm sore; cannot lift arm shoulder height; seeing MD Friday 10/10/14.
Arm aches; Was like I had the flu for 24 hours; This case was reported by a consumer via interactive digital media and described the occurrence of influenza in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced influenza and pain in arm. On an unknown date, the outcome of the influenza and pain in arm were recovered/resolved.   It was unknown if the reporter considered the influenza and pain in arm to be related to Shingles vaccine.     Linked case(s) involving the same patient:  US2022AMR120648   Additional Information: GSK Receipt Date: 16-AUG-2022 Reporter's Comments: This case was received from consumer via interactive digital media. The reporter reported that the patient received Shingles vaccine. The reporter stated that the patient never had Shingles. The patient received the shot that was not worst ever. The patient had the flu for 24 hours and then the arm aches for a few days. The follow-up could not be possible as no contact details were available. Additional supportive information: For tolerance of 2nd dose refer case US2022AMR120648.; Sender's Comments:  US-GSK-US2022AMR120648:Same patient
SLUGGISH, INJECTION SITE WAS SORE AND TENDER TO TOUCH, ARMPIT WAS SORE, SHORTNESS OF BREATH, FEELS LIKE EYES BURN
10 hrs after administration, fever started and quickly increased. Six hrs later, fever was103.1. Headache chills lethargy, temp stayed at or above 101 for 32 hours.  T then went to 99
child developed a petechial rash that extended from the right thigh at injection site up the right side of her body, including her face and chest on the right side only. She also had a local reaction, with erythema and tenderness at injection site.
Four straight hours of diarrhea starting 5 1/2 hours after injection on Tuesday. Followed by chills the rest of the night with increasing temp., every joint in my body ached, hips, spine, neck and head were on fire. By 1:00 p.m. on Wednesday temp topped out at 102.4, (my normal is high 97's) chills continued. Nausea. No vomiting, but close...and the mere thought of food started the stomach rolling. By Thursday morning temp was down to 101.0, nausea slightly improved. Friday, temp down to 100's, nausea gone and body aches were still there but better. Saturday temp in the 99's, actually hungry. Weak, tired, felt like I had been hit by a bus. It was Sunday before temp finally returned to normal. I'm sole caretaker for my husband and this was not a fun week!
Patient states that he was urinating blood.  It went away for a while, then started back up a week later.
After 1st Anthrax injection on 5/4/99, pt. noted ringing in the ears especially at night.Noted again during hearing test on 10/2/99.
Patient reported adverse event on 8/13/22. Patient presented with redness, swelling, pain, hot to the touch at the injection site. Patient consulted to try antihistamines, acetaminophen or ibuprofen, and ice to relieve symptoms. Patient consulted to seek medical attention from PCP or urgent care in case cellulitis had formed at reaction site. Patient had full range of motion but experienced pronounced discomfort when site touched.
acute coronary syndrome and acute myocardial infarction; acute coronary syndrome and acute myocardial infarction; a painful shingles rash on his chest; Information has been received regarding a case in litigation from a lawyer and consumer, referring to a 61-year-old patient of unknown gender. Information about concurrent condition, historical condition and concomitant medication was unknown.  The patient was prescribed zoster vaccine live (ZOSTAVAX) by a healthcare provider for the long-term prevention of shingles and zoster-related conditions. On or about 05-FEB-2015, the patient was administered the zoster vaccine live (ZOSTAVAX) (dose, frequency and route unknown) at a medical group by a facility administrator.   The patient suffered the following injuries and was diagnosed on the following dates as a result of the zoster vaccine live (ZOSTAVAX): the patient experienced a painful shingles rash on his chest, which was diagnosed on 24-DEC-2015. A few weeks later, the patient experienced intermittent pain in his left chest radiating to his left shoulder and arm. The patient was hospitalized and diagnosed with acute coronary syndrome and acute myocardial infarction, which were diagnosed on 15-JAN-2016. The outcome of the events was unknown. All the events were considered to be related to zoster vaccine live (ZOSTAVAX).   Upon internal review, the events acute coronary syndrome and acute myocardial infarction were considered to be medically significant.
The staff member was given a Covid-19 vaccination as part of the LTCF Covid-19 clinic scheduled on 2/25/2021. During  the 20 minute observation period the patient lost consciousness and begin to have seizure-like shaking. An 0.3mg epi-pen was administered in the lateral thigh.  The patient then experienced cardiac arrest at which point nurses from the LTCF began and completed 2 cycles of CPR before the staff member was resuscitated. EMS arrived and assessed the patient. Patient was taken to the hospital for further evaluation.
HEADACHE, NAUSEA, RIGHT KNEE PAIN, LYMPH NODE ON LEFT SIDE (MARBLE SIZE), CHILLS, NO FEVER
Information has been received from a 62 year old female consumer with penicillin allergy who on 10-MAR-2008 was vaccinated with a dose of zoster vaccine live (Oka/Merck) (lot # not available) that was "injected in the arm." Concomitant therapy included ACTONEL and XALATAN. On that same day"after receiving the vaccination the injection site became red, itchy warm, painful and swollen." The patient sought unspecified medical attention. No labs or diagnostic studies were performed. The patient was not recovered at the time of this report. There was no product quality complaint. Additional information has been requested.
Swelling, redness and itching at site. 2nd day post vax fever, chills body aches lethargy. In bed 18 hours post onset of symptoms which began apprx 21 hrs post 2nd vax. Fever chills body aches and lethargy gone after 18 hrs, but radh and swelling persisting to present Apr 5 5:44  p.m.
This spontaneous report as received from a nurse refers to a patient of unknown age and gender. On 15-MAR-2017, the patient was vaccinated with improperly stored dose of VARIVAX lot # M025871, expiration date: 24-MAY-2018 (site, dose and route of administration were not reported). The reason of the call was temperature alarm received via Digital Data Logger. It was reported that the vaccine was exposed to temperature of -14.4 Celsius degrees for 54 minutes before administration to the patient. No previous temperature excursion was reported. No adverse effects were reported. This is one of several reports received from the same source. Additional information is not expected as all required data has been obtained. Sender's Comments: US-009507513-1611USA004113.
Information regarding Prevnar (pneumococcal 7-valent conjugate vaccine( diphtheria crml97 protein) injection) was received from a healthcare professional regarding a 9 month old male patinet who experienced agitation, diarrhea, vomiting. At 9 months of age, the pt received the fourth dose on 01/22/05 only 2 months after receipt of the third dose. Event Details: The patient was inadvertently administered a fourth dose only 2 months after receipt of the 3rd dose. He experienced agitation, diarrhea, and vomiting on 01/22/05. He was taken to the ER by his mother. He was given Rocephin and his vomiting worsened. The child's mother stated that he had received Rocephin before without complications. The child was released the same day.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a non-contactable reporter(s) (Nurse). The reporter is the patient. A 68-year-old female patient (not pregnant) received bnt162b2 omi xbb.1.5 (COMIRNATY (2023-2024 FORMULA)), on 29Sep2023 as dose 1, single at the age of 68 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Hypertension controlled"; "hypothyroidism"; "Asthma"; "obesity"; "Sulfa drugs p allergy"; "Penicillin allergy". The patient's concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (dose 3 (booster), single, manufacturer unknown), for COVID-19 immunization; Covid-19 vaccine (primary immunization series completed, manufacturer unknown), for Covid-19 Immunization. The following information was reported: VACCINATION FAILURE(medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "Treatment of COVID-19". Therapeutic measures were taken as a result of vaccination failure, covid-19, including Paxlovid from 29Oct2023 to 03Nov2023.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Based on the known the information available the Causal relation between the events vaccination failure, Covid 19 and suspect drug cannot be excluded completely
This spontaneous report as received from a pharmacist refers to a patient of unknown age and gender. The patient's pertinent medical history, drug reactions or allergies and concomitant medications were not reported. On 28-JUN-2016, the patient was vaccinated with the second adult dose of RECOMBIVAX HB (dose, route of administration and lot # were not reported), that was expired in February 2016. No adverse effects were reported. Additional information has been requested.
Pt given OPV developed fever to 102F x 12hr, shril cry x 4hrs, beginning 2h after shot.
Hyperemic swelling at Lt leg (thigh) shot site within 24 hrs of vaccine.
This spontaneous report as received from a pharmacy technician refers to a 1-year-old patient of unknown gender. The patient's concurrent conditions, medical history, drug reactions/allergies and, concomitant medications were not reported. On 06-FEB-2018 the patient was vaccinated with improperly stored dose of VARIVAX (lot # N022979, expiry date: 23-AUG-2019) (dose, frequency and route were not reported) for prophylaxis. No adverse effect was reported. The VARIVAX temperature excursion occurred on 14-DEC-2017 and 30-DEC-2017. On 14-DEC-2017, the vaccine was exposed to the temperature of 16.9 degree Fahrenheit (F) for 30 minutes. On 30-DEC-2017, the vaccine was exposed to the temperature of 6 degree Fahrenheit (F) to 14 degree F for 30 minutes. It was reported that the event was because of data logger. No product quality complaint was involved. This is one of the several reports received from the same reporter. Sender's Comments: US-009507513-1802USA001558.
Urinary pain, herpes like rash, post herpetic neuropathy, primarily on the left side. severe nerve pain, severe rash.
Patient was given Moderna at age 17. Patient stated nothing irregular from shot and experienced expected minor pain at injection site.
Injection site hot to touch, red, swollen, blistering. Necessitated a doctor office visit. Prescribed cephalexin 500 mg TID for 10 days.
RA; Lupus; Graves; vertigo; dizziness; This is a spontaneous report from a contactable consumer (patient). A 43-year-old female non-pregnant patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration, administered in left arm on 23Aug2021 14:30 (Batch/Lot Number: Fc3128) as dose 1, single for covid-19 immunisation. Medical history included Known allergies: Citrate, graves, lupus, RA auto immune. No covid prior vaccination. No covid tested post vaccination. Concomitant medications included vitamin D NOS (VITAMIN D); ascorbic acid (VITAMIN C); selinum coreanum (reported as selinum); zinc; alprazolam (reported as aloprozam). Facility type vaccine: Pharmacy or Drug Store. No other vaccine in four weeks.  The patient experienced RA, lupus, graves, vertigo, dizziness, all on 07Sep2021 07:30 with outcome of not recovered.   Ae resulted in: Doctor or other healthcare professional office/clinic visit. No treatment received for the events.   No follow-up attempts are needed. No further information is expected.
I was diagnosed as Benign paroxysmal positional vertigo, BPPV. I received physical therapy for it. The acute symptoms are gone, and the crystals are back where they belong. I still have ongoing balance issues but not the vertigo.
pt recv vax 28APR95 & 4MAY95 lab eval revealed SGOT 71;no further details were provided;
I started to feel achy all over my body. I was having chills as well. I was still able to work throughout the day 1/7/21. I've had a pain in my right arm pit that hasn't gone away. I feel a lump that is moveable and about 1 cm in diameter that is painful constantly and when I message it in my right arm pit. I feel fine otherwise 1/8/21 morning and am still going to work.
1st HB vaccine administered (deltoid) at about 15:15 on 6/28/01. On 6/29/01 at about 09:00, headache began and it advanced to a migraine associated with nausea. Hot and cold flashes began about 11:30 AM. Was very weak at 16:00 and continued until about 20:00. Was well by Monday.
Three days after receiving my first dose of the Pfizer COVID-19 vaccine, I began menstruating 5 days ahead of schedule. My period has been regular for years now so it was unusual for it to begin so early, it has also continued longer than usual. Typically my periods last 5 days at most, but this one is still continuing on day 8. Other than the unusual timing and long duration, there does not seem to be anything concerning about it but I felt I should report it incase this turns out to be a significant side effect of the vaccine.
When diluting the vaccine with Normal saline it appears that I diluted with a volume less than 1.8ml.  I had drawn up 3 X 0.3ml doses and was working on a 4th dose, but there was not enough in the vial to get another 0.3ml dose.  As soon as this was noticed, we tried to retrieve the 3 doses that had been drawn up, but this and one more had been administered.  No immediate reaction occurred.
Information has been received from a physician concerning a 15 month old male with asthma, eczema, and eggs allergy with anaphylactic reactions and a history of allergic rashes who on 07/12/01 was  vaccinated with the first dose  of MMRII, SC in the right arm. this does not comply with the recommended dosage. concomitant therapy included albuterol. there was no illness at the time of vaccination. It was reported that within 10 minutes (also reported as 30 minutes) of vaccination the child developed hives "everywhere"but no wheezing. There was no reaction at the site of injection. it was noted that the patient had a history of asthma and many allergic reactions. The patient responded to diphenhydramine HC(Benadryl). It was also reported that on 05/05/01, the patient received the first dose of Varivax  SC in the left arm and had no adverse reactions. FOLLOW-UP information, reported that the physician "administered 0.1 cc of the vaccine because the mother thought the child might be allergic to MMRII, although the child received a previous dose of Varivax without complications". No further information is expected.